NuScale Power (SMR) 10-Q 9 Aug 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2024	Aug. 05, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	001-04321
Entity Registrant Name	NUSCALE POWER CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-1588588
Entity Address, Address Line One	12725 SW 66th Ave Suite 107
Entity Address, City or Town	Portland
Entity Address, State or Province	OR
Entity Address, Postal Zip Code	97223
City Area Code	971
Local Phone Number	371-1592
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001822966
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false
Class A
Entity Information [Line Items]
Title of 12(b) Security	Class A common stock, $0.0001 par value per share
Trading Symbol	SMR
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		94,715,714
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Entity Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Trading Symbol	SMR.WS
Security Exchange Name	NYSE
Class B
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		154,464,735

Condensed Consolidated Balance

Condensed Consolidated Balance Sheet - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 130,934	$ 120,265
Restricted cash	5,100	5,100
Prepaid expenses	11,866	19,054
Accounts and other receivables	8,375	10,127
Total current assets	156,275	154,546
Property, plant and equipment, net	3,150	4,116
In-process research and development	16,900	16,900
Intangible assets, net	793	882
Goodwill	8,255	8,255
Long-lead material work in process	41,227	36,361
Other assets	2,633	3,798
Total Assets	229,233	224,858
Current Liabilities
Accounts payable and accrued expenses	19,098	44,925
Accrued compensation	5,734	8,546
Long-lead material liability	32,445	32,323
Other accrued liabilities	1,540	1,664
Total current liabilities	58,817	87,458
Warrant liabilities	51,500	5,722
Noncurrent accounts payable and accrued expenses	24,880	0
Other noncurrent liabilities	647	1,442
Deferred revenue	78	898
Total Liabilities	135,922	95,520
Stockholders’ Equity
Additional paid-in capital	420,948	333,888
Accumulated deficit	(284,643)	(240,454)
Total Stockholders’ Equity Excluding Noncontrolling Interests	136,329	93,457
Noncontrolling interests	(43,018)	35,881
Total Stockholders' Equity	93,311	129,338
Total Liabilities and Stockholders' Equity	229,233	224,858
Class A
Stockholders’ Equity
Common stock, value	9	8
Class B
Stockholders’ Equity
Common stock, value	$ 15	$ 15

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheet (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Class A
Common stock, par value (usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (shares)	332,000,000	332,000,000
Common stock, shares outstanding (shares)	92,486,358	76,895,166
Class B
Common stock, par value (usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (shares)	179,000,000	179,000,000
Common stock, shares outstanding (shares)	154,464,735	154,477,032

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenue	$ 967,000	$ 5,795,000	$ 2,346,000	$ 11,300,000
Cost of sales	(850,000)	(5,765,000)	(1,585,000)	(9,181,000)
Gross Margin	117,000	30,000	761,000	2,119,000
Research and development expenses	12,132,000	26,932,000	25,287,000	54,502,000
General and administrative expenses	16,827,000	16,323,000	36,186,000	31,018,000
Other expenses	13,036,000	12,896,000	25,139,000	28,192,000
Loss From Operations	(41,878,000)	(56,121,000)	(85,851,000)	(111,593,000)
Sponsored cost share	2,448,000	16,337,000	5,844,000	34,210,000
Change in fair value of warrant liabilities	(36,733,000)	7,199,000	(45,778,000)	6,091,000
Interest income	1,725,000	2,851,000	3,267,000	5,948,000
Loss Before Income Taxes	(74,438,000)	(29,734,000)	(122,518,000)	(65,344,000)
Provision (benefit) for income taxes	0	0	0	0
Net Loss	(74,438,000)	(29,734,000)	(122,518,000)	(65,344,000)
Net loss attributable to noncontrolling interests	(46,821,000)	(20,211,000)	(78,329,000)	(44,859,000)
Net Loss Attributable to Class A Common Stockholders	$ (27,617,000)	$ (9,523,000)	$ (44,189,000)	$ (20,485,000)
Loss per Share of Class A Common Stock:
Basic (usd per share)	$ (0.31)	$ (0.13)	$ (0.52)	$ (0.29)
Diluted (usd per share)	$ (0.31)	$ (0.13)	$ (0.52)	$ (0.29)
Weighted-Average Shares of Class A Common Stock Outstanding:
Basic (shares)	89,553,679	72,125,375	84,569,371	70,913,646
Diluted (shares)	89,553,679	72,125,375	84,569,371	70,913,646

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Total	Class A	Class B	Common Stock Class A	Common Stock Class B	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interests
Beginning balance (shares) at Dec. 31, 2022				69,353,000	157,091,000
Beginning balance at Dec. 31, 2022	$ 277,087			$ 7	$ 16	$ 296,748	$ (182,092)	$ 162,408
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	8,090					8,090
Exercise of common share options and warrants and vested RSUs (shares)				2,321,000
Exercise of common share options and warrants and vested RSUs	4,371					4,371
Exchange of combined interests into Class A common stock (shares)				2,371,000	(2,371,000)
Exchange of combined interests into Class A common stock	0
Rebalancing of ownership percentage for exchange of combined interest into Class A shares	0					3,409		(3,409)
Net loss	(65,344)						(20,485)	(44,859)
Ending balance (shares) at Jun. 30, 2023				74,045,000	154,720,000
Ending balance at Jun. 30, 2023	224,204			$ 7	$ 16	312,618	(202,577)	114,140
Beginning balance (shares) at Mar. 31, 2023				70,061,000	157,091,000
Beginning balance at Mar. 31, 2023	246,731			$ 7	$ 16	302,487	(193,054)	137,275
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	4,453					4,453
Exercise of common share options and warrants and vested RSUs (shares)				1,613,000
Exercise of common share options and warrants and vested RSUs	2,754					2,754
Exchange of combined interests into Class A common stock (shares)				2,371,000	(2,371,000)
Exchange of combined interests into Class A common stock	0
Rebalancing of ownership percentage for exchange of combined interest into Class A shares	0					2,924		(2,924)
Net loss	(29,734)						(9,523)	(20,211)
Ending balance (shares) at Jun. 30, 2023				74,045,000	154,720,000
Ending balance at Jun. 30, 2023	224,204			$ 7	$ 16	312,618	(202,577)	114,140
Beginning balance (shares) at Dec. 31, 2023		76,895,166	154,477,032	76,895,000	154,477,000
Beginning balance at Dec. 31, 2023	129,338			$ 8	$ 15	333,888	(240,454)	35,881
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	6,496					6,496
Exercise of common share options and warrants and vested RSUs (shares)				2,882,000
Exercise of common share options and warrants and vested RSUs	7,354					7,354
Issuance of Class A common stock (shares)				12,697,000
Issuance of Class A common stock	72,641			$ 1		72,640
Exchange of combined interests into Class A common stock (shares)				12,000	(12,000)
Exchange of combined interests into Class A common stock	0
Rebalancing of ownership percentage for exchange of combined interest into Class A shares	0					570		(570)
Net loss	(122,518)						(44,189)	(78,329)
Ending balance (shares) at Jun. 30, 2024		92,486,358	154,464,735	92,486,000	154,465,000
Ending balance at Jun. 30, 2024	93,311			$ 9	$ 15	420,948	(284,643)	(43,018)
Beginning balance (shares) at Mar. 31, 2024				86,760,000	154,473,000
Beginning balance at Mar. 31, 2024	128,691			$ 9	$ 15	382,068	(257,026)	3,625
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	4,278					4,278
Exercise of common share options and warrants and vested RSUs (shares)				1,520,000
Exercise of common share options and warrants and vested RSUs	3,754					3,754
Issuance of Class A common stock (shares)				4,198,000
Issuance of Class A common stock	31,026					31,026
Exchange of combined interests into Class A common stock (shares)				8,000	(8,000)
Exchange of combined interests into Class A common stock	0
Rebalancing of ownership percentage for exchange of combined interest into Class A shares	0					(178)		178
Net loss	(74,438)						(27,617)	(46,821)
Ending balance (shares) at Jun. 30, 2024		92,486,358	154,464,735	92,486,000	154,465,000
Ending balance at Jun. 30, 2024	$ 93,311			$ 9	$ 15	$ 420,948	$ (284,643)	$ (43,018)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
OPERATING CASH FLOW
Net Loss	$ (122,518)	$ (65,344)
Adjustments to reconcile net loss to operating cash flow:
Depreciation	892	1,172
Amortization of intangibles	89	89
Equity-based compensation expense	6,496	8,090
Impairment of intangible asset	71	0
Gain on insurance proceeds received for damage to property, plant and equipment	(122)	0
Change in fair value of warrant liabilities	45,778	(6,091)
Net noncash change in right of use assets and lease liabilities	(187)	10
Changes in assets and liabilities:
Prepaid expenses and other assets	7,676	(2,567)
Accounts receivable	1,752	(13,721)
Long-term contract work in process	(4,866)	(23,900)
Long-lead material liability	122	0
Accounts payable and accrued expenses	(273)	327
Lease liability	(799)	(720)
Deferred revenue	(820)	22,923
Accrued compensation	(2,812)	(2,635)
Net Cash Used in Operating Activities	(69,521)	(82,367)
INVESTING CASH FLOW
Sale of short-term investments	0	50,000
Insurance proceeds received for damage to property, plant and equipment	195	0
Purchases of property, plant and equipment	0	(1,620)
Net Cash Provided by Investing Activities	195	48,380
FINANCING CASH FLOW
Proceeds from the issuance of common stock, net of issuance fees	72,641	0
Proceeds from exercise of warrants and common share options	7,354	4,371
Net Cash Provided by Financing Activities	79,995	4,371
Net Change in Cash, Cash Equivalents and Restricted Cash	10,669	(29,616)
Cash, cash equivalents and restricted cash:
Beginning of period	125,365	244,217
End of period	136,034	214,601
Summary of Noncash Investing and Financing Activities:
Plant, property and equipment in accounts payable	$ 0	$ 19

Nature of Business

Nature of Business	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	Nature of Business Organization NuScale Corp (“NuScale”, the “Company”, “us”, “we” or “our”) is incorporated under the laws of the state of Delaware. The Company is the primary beneficiary of NuScale LLC, a variable interest entity, and all activity of NuScale LLC and the Company are consolidated herein. NuScale LLC is a limited liability company organized in the State of Oregon in 2011. The Company is majority owned by Fluor Enterprises, Inc., a subsidiary of Fluor Corporation. Operations The Company is commercializing a modular, scalable 77 megawatt (gross) electric Light Water Reactor nuclear power plant using exclusive rights to a nuclear power plant design obtained from Oregon State University (“OSU”). The following represents key milestones in the development of this technology: • December 2016: DCA completed • January 2017: DCA submitted to the NRC • March 2017: DCA accepted for review by the NRC • August 2020: NRC issued the Final Safety Evaluation Report ("FSER") • July 2023: SDA Application and associated licensing topical reports accepted for formal review by the NRC The FSER represents the NRC’s completion of its technical review and approval of the NuScale SMR design. With this final phase of NuScale’s DCA now complete, customers may proceed with plans to develop NuScale power plants with the understanding that the NRC has approved the safety aspects of the NuScale design. Based on the NRC’s published schedule for SDA Application review, we expect the NRC will complete its review and SDA approval to be received by July 31, 2025. The majority of the Company’s operations and long-lived assets were attributable to operations in the United States other than the long-lead material work in process being manufactured in South Korea during the 2023 and 2024 fiscal years. On January 5, 2024, NuScale announced a plan to reduce the Company’s workforce by 154 full time employees, or 28%, in order to continue our transition from a R&D-based company to a commercial company. This resulted in a one-time charge of $3,236 during the six months ended June 30, 2024 . As a result of the cost-cutting plans implemented by management, the utilization of our ATM Program and the execution of a customer contract subsequent to June 30, 2024, we believe we will have sufficient funds available to cover required R&D activities and operating cash needs for the next twelve months. Subsequent to June 30, 2024, the Company executed a revenue generating agreement with RoPower Nuclear S.A. (“RoPower”) in relation to the advancement of Doicesti project Phase 2 Front-End Engineering Design, a project which targets the development of six NuScale power modules at a former coal plant site in Doicești, Romania.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The Company’s unaudited condensed consolidated financial statements and related notes do not include notes and certain financial information normally presented annually under GAAP, and therefore should be read in conjunction with our 2023 Form 10-K. Accounting measures at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year. These financial statements are unaudited. In management’s opinion, they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the interim periods presented. Principles of Consolidation As part of the Transaction, NuScale Corp has been determined to be the primary beneficiary of NuScale LLC, a variable interest entity (“VIE”). As the sole managing member of NuScale LLC, NuScale Corp has both the power to direct the activities, and direct ownership to share in the revenues and expenses of NuScale LLC. As such, all the activity of NuScale LLC has been consolidated in the accompanying condensed consolidated financial statements. All assets and liabilities included in the balance sheet are that of NuScale LLC, other than the NuScale Corp Warrants and certain prepaid assets. All significant intercompany transactions have been eliminated upon consolidation. Changes in Presentation For the six months ended June 30, 2023 , amounts totaling $1,855 were reclassified out of Other expenses and into R&D expenses to conform to the current year presentation. Cash, Cash Equivalents and Restricted Cash Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase, while cash equivalents with an initial maturity of between three and twelve months at time of purchase are considered short-term investments. The Company’s cash equivalents consist of certificates of deposit, are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost. Cash in the amount of $5,100 is restricted as collateral for the letter of credit associated with the Release Agreement with CFPP LLC at June 30, 2024 and December 31, 2023, and is identified as Restricted cash in the condensed consolidated balance sheet. The restricted cash balance plus cash and cash equivalents on the condensed consolidated balance sheet equals cash, cash equivalents and restricted cash, as reflected in the condensed consolidated statements of cash flows. Sales and Marketing Agreements The Company has entered into sales and marketing agreements pursuant to which it prepaid certain expenses to the counterparty. As of June 30, 2024 and December 31, 2023, the balance of $7,500 and $15,000, respectively, is included in Prepaid expenses on the accompanying condensed consolidated balance sheet and will be amortized monthly on a straight-line basis through December 31, 2024. Warrant Liability The Company accounts for the Warrants in accordance with the guidance contained in Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging”, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The fair value of the Public and Private Placement Warrants has been estimated using the Public Warrants’ quoted market price. Sponsored Cost Share As our commercialization activities advance, we have continued to enter into cost share agreements with various entities, including both governmental and private, under which the Company is reimbursed for specific R&D activities. As of June 30, 2024 , these entities include the United States Department of State and United States Trade and Development Agency (combined as “USG”), RoPower, DOE and CFPP LLC. Beginning in 2021, the Company partnered with USG to develop SMRs in foreign markets. Under USG’s technical assistance grant programs, we receive cost share commitments to support licensing work in these foreign markets, one of which is additionally supported by RoPower. During the three months ended June 30, 2024 and 2023 , USG cost share totaled $2,397 and $6,882, respectively, while during the six months ended June 30, 2024 and 2023 , USG cost share totaled $5,192 and $9,297, respectively. Since 2014, DOE has provided critical funding to the Company through a series of cooperative agreements that support ongoing commercialization activities. Although we did not receive any cost share from DOE during the second quarter, during the six months ended June 30, 2024, DOE cost share totaled $336. During the three and six months ended June 30, 2023, DOE cost share totaled $7,193 and $19,547, respectively. Finally, we receive subrecipient cost share from CFPP LLC under a contract between the DOE and UAMPS for R&D performed with the goal of developing our first SMR. Under this agreement we received cost share of $51 and $2,165 during the three months ended June 30, 2024 and 2023 , respectively, while for the six months ended June 30, 2024 and 2023, the Company received cost share of $316 and $5,104, respectively . Recent Accounting Pronouncements Management believes there is no new accounting guidance issued but not yet effective that would have a material impact to the Company’s current financial statements.

Noncontrolling Interests and Lo

Noncontrolling Interests and Loss Per Share	6 Months Ended
	Jun. 30, 2024
Noncontrolling Interest And Loss Per Share [Abstract]
Noncontrolling Interests and Loss Per Share	Noncontrolling Interests and Loss Per Share Noncontrolling Interests Following the Transaction, holders of Class A common stock own direct controlling interests in the results of the combined entity, while the Legacy NuScale Equityholders own an economic interest in NuScale LLC, shown as noncontrolling interests (“NCI”) in equity in NuScale Corp’s condensed consolidated financial statements. The indirect economic interests are held by Legacy NuScale Equityholders in the form of NuScale LLC Class B Units. The following table summarizes the economic interests of NuScale Corp between the holders of Class A common stock and indirect economic interests held by NuScale LLC Class B unitholders. As of and for the Three Months Ended June 30, As of and for the Six Months Ended June 30, Noncontrolling Interests 2024 2023 2024 2023 NuScale Corp Class A common stock Beginning of period 86,760,243 70,061,055 76,895,166 69,353,019 Exchange of combined interests into Class A common stock 8,660 2,370,805 12,297 2,370,805 Issuance of Class A common stock 4,198,064 — 12,696,994 — Exercise of options, warrants and vested RSUs 1,519,391 1,613,346 2,881,901 2,321,382 End of period 92,486,358 74,045,206 92,486,358 74,045,206 NuScale LLC Class B Units (NCI) Beginning of period 154,473,395 157,090,820 154,477,032 157,090,820 Exchange of combined interests into Class A common stock (8,660) (2,370,805) (12,297) (2,370,805) End of period 154,464,735 154,720,015 154,464,735 154,720,015 Total Beginning of period 241,233,638 227,151,875 231,372,198 226,443,839 Issuance of Class A common stock 4,198,064 — 12,696,994 — Exercise of options, warrants and vested RSUs 1,519,391 1,613,346 2,881,901 2,321,382 End of period 246,951,093 228,765,221 246,951,093 228,765,221 Ownership Percentage NuScale Corp Class A common stock Beginning of period 36.0 % 30.8 % 33.2 % 30.6 % End of period 37.5 % 32.4 % 37.5 % 32.4 % NuScale LLC Class B Units (NCI) Beginning of period 64.0 % 69.2 % 66.8 % 69.4 % End of period 62.5 % 67.6 % 62.5 % 67.6 % The NCI may decrease according to the number of shares of Class B common stock and NuScale LLC Class B units that are exchanged for shares of Class A common stock or, in certain circumstances including at the election of NuScale Corp, cash in an amount equal to the fair value of Class A common stock received in a contemporaneous equity issuance. After each exchange, NuScale LLC equity attributable to NuScale Corp is rebalanced to reflect the change in ownership percentage, which is calculated above based on Class B units and Class A shares, as a percentage of Combined interests. Loss Per Share Basic loss per share is based on the average number of shares of Class A common stock outstanding during the period. Diluted loss per share is based on the average number of shares of Class A common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of RSUs, Stock Options and Warrants using the “treasury stock” method and for all other interests that convert into potential shares of Class A common stock, if any, using the “if converted” method. Net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the Company’s share of NuScale LLC’s net loss, net of NuScale Corp taxes, after giving effect to all other interests that convert into potential shares of Class A common stock, to the extent it is dilutive. In addition, net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the after-tax impact of changes to the fair value of derivative liabilities, to the extent the Company’s Warrants are dilutive. The following table sets forth the computation of basic and diluted net loss per share of Class A common stock. Class B common stock represents a right to cast one vote per share at the NuScale Corp level, and carries no economic rights, including rights to dividends or distributions upon liquidation, and as a result, is not considered a participating security for basic and diluted loss per share. As such, basic and diluted loss per share of Class B common stock has not been presented. As of and for the Three Months Ended June 30, As of and for the Six Months Ended June 30, (in thousands, except share and per share amounts) 2024 2023 2024 2023 Net loss attributable to Class A common stockholders $ (27,617) $ (9,523) $ (44,189) $ (20,485) Weighted-average shares for basic and diluted loss per share 89,553,679 72,125,375 84,569,371 70,913,646 Basic and Diluted loss per share of Class A common stock $ (0.31) $ (0.13) $ (0.52) $ (0.29) Anti-dilutive securities excluded from shares outstanding: Shares of Class B common stock 154,464,735 154,720,015 154,464,735 154,720,015 Stock options 9,884,004 10,413,895 9,884,004 10,413,895 Warrants 18,458,701 18,458,701 18,458,701 18,458,701 Time-based RSUs 5,975,343 3,301,761 5,975,343 3,301,761 Total 188,782,783 186,894,372 188,782,783 186,894,372 During the three and six months ended June 30, 2024, the Company issued and sold shares of Class A common stock in the amount of 4,198,064 and 12,696,994, respectively, at a weighted average price of $7.58 and $5.87 per share, respectively. During the three months ended June 30, 2024, the ATM Program generated gross and net proceeds of $31,821 and $31,025, respectively, while for the six months ended June 30, 2024 the ATM Program generated gross and net proceeds of $74,502 and $72,639, respectively. As of June 30, 2024, we have 5,565,628 shares of Class A common stock authorized and available under the ATM Program at an aggregate sales price of up to $65,142. Subsequent to June 30, 2024, the Company issued and sold 1,420,391 shares of Class A common stock under the ATM Program for the gross and net proceeds of $18,858 and $18,386, respectively.

Warrant Liabilities

Warrant Liabilities	6 Months Ended
	Jun. 30, 2024
Warrants and Rights Note Disclosure [Abstract]
Warrant Liabilities	Warrant Liabilities Under the Company’s Warrant Agreement, when Private Placement Warrants are transferred by Spring Valley Acquisition Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), to persons who are not “Permitted Transferees” (as defined in the Warrant Agreement) of the Sponsor, they cease to be Private Placement Warrants and become Public Warrants under the Warrant Agreement. The Company has been informed by the Sponsor that the Private Placement Warrants were transferred in accordance with the Warrant Agreement to persons who are not Permitted Transferees. Consequently, the previously described Private Placement Warrants are now Public Warrants under the Warrant Agreement, resulting in all 18,458,701 warrants identified as Public Warrants in Note 5, Fair Value Measurement , as of June 30, 2024. Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants are currently exercisable and will expire on May 2, 2027 (five years from the date of the Transaction) or earlier upon redemption or liquidation. Redemption of Warrants when the price per share of Class A common stock equals or exceeds $18.00 . The Company may redeem the outstanding Warrants: • in whole and not in part; • at a price of $0.01 per Warrant; • upon a minimum of 30 days prior written notice of redemption to each Warrant holder; and • if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders. The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. If and when the Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00 . The Company may redeem the outstanding Warrants: • in whole and not in part; • at $0.10 per Warrant upon a minimum of 30 days prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined as set forth in the Warrant Agreement, based on the redemption date and the fair market value of the Class A common stock, subject to certain exceptions; and • if, and only if, the closing price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant based on anti-dilution adjustments set forth in the Warrant Agreement) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders. The Warrants may be exercised for cash (or on a cashless basis as described above in “- Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00” ) at any time after notice of redemption shall have been given by the Company and prior to the redemption date. For a complete description of the Warrants, please see the Warrant Agreement, which is Exhibit 4.2 to the 2023 Form 10-K, and the section entitled “Warrants” in the “Description of Registrant’s Securities,” which is Exhibit 4.3 to the 2023 Form 10-K.

Fair Value Measurement

Fair Value Measurement	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair Value Measurement The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach). The levels of hierarchy are described below: Level 1 Quoted prices in active markets for identical instruments; Level 2 Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and Level 3 Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement. The carrying amount of certain financial instruments, including deposits, accounts payable and accrued expenses, approximates fair value due to their short maturities. Our Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in fair value of the Warrants are recorded in the statement of operations each period. As discussed in Note 4, Warrant Liabilities , because the Private Placement Warrants are no longer held by the Sponsor or a “Permitted Transferee” of the Sponsor, the Private Placement Warrants are Public Warrants under the Warrant Agreement. In light of these circumstances, we have classified both the Private Placement Warrants and the Public Warrants as Level 1 as of June 30, 2024. The following tables represents the Company’s financial liabilities measured at fair value on a recurring basis: (in thousands) Level 1 Level 2 Level 3 Total Warrant Liabilities: Public Warrants $ 51,500 $ — $ — $ 51,500 Total Warrant Liabilities as of June 30, 2024 $ 51,500 $ — $ — $ 51,500 (in thousands) Level 1 Level 2 Level 3 Total Warrant Liabilities: Public Warrants $ 2,963 $ — $ — $ 2,963 Private Placement Warrants — 2,759 — 2,759 Total Warrant Liabilities as of December 31, 2023 $ 2,963 $ 2,759 $ — $ 5,722

Accounts and Other Receivables

Accounts and Other Receivables	6 Months Ended
	Jun. 30, 2024
Receivables [Abstract]
Accounts and Other Receivables	Accounts and Other Receivables Accounts and other receivables include reimbursement requests outstanding from the cost share awards, interest receivable and commercial accounts receivable. The cost share reimbursement requests are recognized as eligible costs are incurred. Reimbursement under the awards is recognized as award funds are obligated, and are included in Sponsored cost share in the condensed consolidated statement of operations. Interest receivable of $431 and $318 was outstanding at June 30, 2024 and December 31, 2023, respectively. The majority of our receivables are either due from the U.S. federal government or have to do with a federal project. For these reasons, all receivables are deemed to be fully collectible and no allowance has been recorded.

Property, Plant and Equipment

Property, Plant and Equipment	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment consisted of the following: (in thousands) June 30, 2024 December 31, 2023 Furniture and fixtures $ 27 $ 27 Office and computer equipment 7,222 7,274 Software 13,898 14,102 Operations equipment 1,165 1,165 Leasehold improvements 2,189 2,293 24,501 24,861 Less: Accumulated depreciation (21,351) (20,745) Net property, plant and equipment $ 3,150 $ 4,116 Depreciation of property, plant and equipment for the three months ended June 30, 2024 and 2023 was $402 and $556, respectively. Of these amounts, $80 and $322 is included in G&A expenses and Other expense, respectively, for the 2024 fiscal year and $137 and $419, respectively, for the 2023 fiscal year. Depreciation of property, plant and equipment for the six months ended June 30, 2024 and 2023 was $892 and $1,172, respectively. Of these amounts, $174 and $718 is included in G&A expenses and Other expense, respectively, for the 2024 fiscal year and $277 and $895, respectively, for the 2023 fiscal year.

Long-Lead Material Work In Proc

Long-Lead Material Work In Process and Liability	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
Long-Lead Material Work In Process and Liability	Long-Lead Material Work In Process and Liability During the first quarter of 2023, we entered into the LLM Agreement with CFPP LLC. Related to this contract, the Company has subcontracted for the purchase of certain long-lead materials (“LLM”) in the amount of $55,700, that were to be used in fabrication of the NPMs as part of the DCRA with CFPP LLC. However, on November 7, 2023, NuScale and CFPP LLC entered into the Release Agreement whereby the DCRA and LLM Agreement would be suspended, while wind down procedures and the ultimate disposition of the long-lead materials would be negotiated between the Company, CFPP LLC and DOE. As part of the Release Agreement, NuScale was required to pay $49,769 to CFPP LLC and provide a letter of credit in the amount of $5,000 for demobilization and wind down costs. This letter of credit is collateralized by $5,100 and included in the accompanying condensed consolidated balance sheet as Restricted cash as of June 30, 2024 and December 31, 2023. Upon final settlement of the LLM Agreement, and once DOE is compensated for its investment in the LLM (stemming from DOE’s funding under its cost share agreement with CFPP LLC), NuScale will obtain all rights and obligations of the LLM. As a result of DOE’s investment in the LLM, as of June 30, 2024 and December 31, 2023 , NuScale has included a Long-lead material liability on the accompanying condensed consolidated balance sheet in the amount of $32,445 , for the estimated cost to gain 100% of the LLM, once completed. The LLM represents in process inventory recorded at cost and is identified as Long-lead material work in process on the condensed consolidated balance sheet in the amount of $41,227 and $36,361 as of June 30, 2024 and December 31, 2023, respectively

Noncurrent Accounts Payable and

Noncurrent Accounts Payable and Accrued Expenses	6 Months Ended
	Jun. 30, 2024
Payables and Accruals [Abstract]
Noncurrent Accounts Payable and Accrued Expenses	Noncurrent Accounts Payable and Accrued Expenses

Employee Benefits

Employee Benefits	6 Months Ended
	Jun. 30, 2024
Retirement Benefits [Abstract]
Employee Benefits	Employee Benefits

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes NuScale LLC was historically and remains a partnership for U.S. federal income tax purposes with each partner being separately taxed on its share of taxable income or loss. NuScale Corp is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to its distributive share of any net taxable income or loss and any related tax credits of NuScale LLC. The effective tax rate was 0% for the three and six months ended June 30, 2024. The effective income tax rate for the three and six months ended June 30, 2024 differed significantly from the statutory rates, primarily due to the losses allocated to NCI and the recognition of a valuation allowance as a result of the Company’s new tax structure following the Transaction. There was no income tax expense recorded during the three and six months ended June 30, 2024. The Company has assessed the realizability of the net deferred tax assets and in that analysis has considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The Company has recorded a full valuation allowance against the deferred tax assets at NuScale Corp as of June 30, 2024, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances. The Company’s income tax filings will be subject to audit by various taxing jurisdictions. The Company will monitor the status of U.S. federal, state and local income tax returns that may be subject to audit in future periods. No U.S. federal, state and local income tax returns are currently under examination by the respective taxing authorities.

Equity-Based Compensation

Equity-Based Compensation	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Equity-Based Compensation	Equity-Based Compensation The total compensation expense recognized for common share options and time-based RSU awards during the three months ended June 30, 2024 and 2023 was $4,277 and $4,453, respectively, and $6,496 and $8,090 for the six months ended June 30, 2024 and 2023, respectively. For the three months ended June 30, 2024, equity-based compensation of $1,981 was included in G&A expense and $2,296 was included in Other expense, compared to $1,868 and $2,585, respectively, over the same periods in the prior year. For the six months ended June 30, 2024, equity based compensation of $3,428 was included in G&A expense and $3,068 included in Other expense compared to $3,361 and $4,729, respectively, over the same periods in the prior year. Stock Options During the six months ended June 30, 2024, the Board approved 2,909,375 employee share option awards, with an aggregate fair value of $6,401, that vest one-third annually starting in February 2025 for a period of three years. The Company measures the fair value of each share option grant at the date of grant using a Black-Scholes option pricing model. Time-based RSUs During the six months ended June 30, 2024, the Company granted employees 4,598,635 RSUs with an aggregate value of $14,716. The RSUs vest one-third annually starting in February 2025. During the three and six months ended June 30, 2024, RSUs totaling 450,332 and 918,239, respectively, vested and the Class A shares were issued.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions From time to time, the Company enters into strategic agreements with Fluor, whereby Fluor or the Company perform services for one another. For the three months ended June 30, 2024 and 2023, we incurred expenses of $291 and $8,479, respectively, while for the six months ended June 30, 2024 and 2023, we incurred expenses of $538 and $17,205, respectively. As of June 30, 2024 and December 31, 2023, the Company owed Fluor, as Accounts payable and accrued expenses on the condensed consolidated balance sheet, amounts totaling $1,233 and $4,080, respectively. For the three months ended June 30, 2024 and 2023, we earned revenue of $523 and $4,756, respectively, and for the six months ended June 30, 2024 and 2023, we earned $523 and $8,770, respectively. As of June 30, 2024 and December 31, 2023, Fluor owed us $523 and $2,642, respectively, amounts which are included in Accounts and other receivables on the condensed consolidated balance sheet. For the three months ended June 30, 2024 and 2023, Fluor accounted for 54% and 82%, respectively, of total revenue, while for the six months ended June 30, 2024 and 2023, they accounted for 22% and 78%, respectively.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies In the regular course of business, the Company is involved in various legal proceedings and claims incidental to the normal course of business. Other than as disclosed immediately below, the Company does not believe that any legal claims are material to the Company. Management does not believe that resolution of any of these matters will materially affect the Company’s financial position or results of operations. On September 19, 2022, thirteen purported members of NuScale LLC filed suit in the U.S. District Court for the District of Oregon against NuScale LLC, Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC. The plaintiffs purport to represent a class of individuals who held common units or options to purchase common units in NuScale LLC and seek declaratory relief and damages based on breach of contract and other common law claims. The claims in the complaint are based on amendments to the operating agreement of NuScale LLC in connection with the Merger between NuScale LLC and Spring Valley Acquisition Corp. NuScale LLC filed a motion to dismiss the complaint on November 21, 2022. Plaintiffs filed a response on January 17, 2023, and NuScale LLC filed a reply on February 14, 2023. A hearing on various motions to dismiss took place on May 17, 2023, and on August 3, 2023, the Magistrate Judge assigned to the case issued a report and recommendation that recommended that NuScale LLC’s motion to dismiss be denied. On August 17, 2023, NuScale LLC filed an objection to the report and recommendation. On November 13, 2023, the District Court Judge entered an order accepting the report and recommendation. On December 8, 2023, Plaintiffs filed a motion for leave to amend their complaint, seeking to add claims and bring back defendants that were dismissed from the complaint at an earlier stage of the litigation (Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC). NuScale LLC and the other defendants opposed the proposed amendment. On May 2, 2024, the Magistrate Judge issued a report and recommendation that recommended that Plaintiffs’ proposed amendment be denied. Plaintiffs did not file an objection to this report, and it was adopted by the District Court Judge on June 24, 2024. That same day, the Court ordered that the parties confer and provide proposed dates for completing discovery and filing any dispositive motions. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions. Two other shareholder class action lawsuits were filed in the U.S. District Court for the District of Oregon against the Company, John Hopkins, Chris Colbert, Robert Hamady and Clayton Scott: (1) Sigman v. NuScale Power Corp., et al. (Case No. 23-1689, filed November 15, 2023), and (2) Ryckewaert v. NuScale Power Corp., et al. (Case No. 23-1956, filed December 26, 2023). These lawsuits assert virtually identical allegations and claims and were consolidated before the same judge on February 2, 2024. The lawsuits assert claims under the federal securities laws and allege that the Company and members of management made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects, and specifically about certain of the Company’s agreements with customers. The Court has appointed lead plaintiff and lead counsel, and they filed an amended complaint on April 18, 2024 that makes similar allegations as the original complaints. Defendants’ filed a motion to dismiss on June 17, 2024. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (27,617)	$ (9,523)	$ (44,189)	$ (20,485)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
José Reyes Jr. [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During the three months ended June 30, 2024, one officer of the Company, José Reyes Jr., terminated his 10b5-1 plan on April 23, 2024.
Name	José Reyes Jr.
Title	officer
Rule 10b5-1 Arrangement Terminated	true
Termination Date	April 23, 2024

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements and related notes do not include notes and certain financial information normally presented annually under GAAP, and therefore should be read in conjunction with our 2023 Form 10-K. Accounting measures at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year. These financial statements are unaudited. In management’s opinion, they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the interim periods presented.
Principles of Consolidation	Principles of Consolidation
Changes in Presentation	Changes in Presentation For the six months ended June 30, 2023
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Restricted Cash Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase, while cash equivalents with an initial maturity of between three and twelve months at time of purchase are considered short-term investments. The Company’s cash equivalents consist of certificates of deposit, are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost. Cash in the amount of $5,100 is restricted as collateral for the letter of credit associated with the Release Agreement with CFPP LLC at June 30, 2024 and December 31, 2023, and is identified as Restricted cash in the condensed consolidated balance sheet. The restricted cash balance plus cash and cash equivalents on the condensed consolidated balance sheet equals cash, cash equivalents and restricted cash, as reflected in the condensed consolidated statements of cash flows.
Sales and Marketing Agreements	Sales and Marketing Agreements The Company has entered into sales and marketing agreements pursuant to which it prepaid certain expenses to the counterparty. As of June 30, 2024 and December 31, 2023, the balance of $7,500 and $15,000, respectively, is included in Prepaid expenses on the accompanying condensed consolidated balance sheet and will be amortized monthly on a straight-line basis through December 31, 2024.
Warrant Liability	Warrant Liability
Sponsored Cost Share	Sponsored Cost Share As our commercialization activities advance, we have continued to enter into cost share agreements with various entities, including both governmental and private, under which the Company is reimbursed for specific R&D activities. As of June 30, 2024
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management believes there is no new accounting guidance issued but not yet effective that would have a material impact to the Company’s current financial statements.
Fair Value Measurement	The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach). The levels of hierarchy are described below: Level 1 Quoted prices in active markets for identical instruments; Level 2 Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and Level 3 Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement. The carrying amount of certain financial instruments, including deposits, accounts payable and accrued expenses, approximates fair value due to their short maturities. Our Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in fair value of the Warrants are recorded in the statement of operations each period. As discussed in Note 4, Warrant Liabilities , because the Private Placement Warrants are no longer held by the Sponsor or a “Permitted Transferee” of the Sponsor, the Private Placement Warrants are Public Warrants under the Warrant Agreement. In light of these circumstances, we have classified both the Private Placement Warrants and the Public Warrants as Level 1 as of June 30, 2024.

Noncontrolling Interests and _2

Noncontrolling Interests and Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2024
Noncontrolling Interest And Loss Per Share [Abstract]
Schedule of Non-Controlling Interests	Following the Transaction, holders of Class A common stock own direct controlling interests in the results of the combined entity, while the Legacy NuScale Equityholders own an economic interest in NuScale LLC, shown as noncontrolling interests (“NCI”) in equity in NuScale Corp’s condensed consolidated financial statements. The indirect economic interests are held by Legacy NuScale Equityholders in the form of NuScale LLC Class B Units. The following table summarizes the economic interests of NuScale Corp between the holders of Class A common stock and indirect economic interests held by NuScale LLC Class B unitholders. As of and for the Three Months Ended June 30, As of and for the Six Months Ended June 30, Noncontrolling Interests 2024 2023 2024 2023 NuScale Corp Class A common stock Beginning of period 86,760,243 70,061,055 76,895,166 69,353,019 Exchange of combined interests into Class A common stock 8,660 2,370,805 12,297 2,370,805 Issuance of Class A common stock 4,198,064 — 12,696,994 — Exercise of options, warrants and vested RSUs 1,519,391 1,613,346 2,881,901 2,321,382 End of period 92,486,358 74,045,206 92,486,358 74,045,206 NuScale LLC Class B Units (NCI) Beginning of period 154,473,395 157,090,820 154,477,032 157,090,820 Exchange of combined interests into Class A common stock (8,660) (2,370,805) (12,297) (2,370,805) End of period 154,464,735 154,720,015 154,464,735 154,720,015 Total Beginning of period 241,233,638 227,151,875 231,372,198 226,443,839 Issuance of Class A common stock 4,198,064 — 12,696,994 — Exercise of options, warrants and vested RSUs 1,519,391 1,613,346 2,881,901 2,321,382 End of period 246,951,093 228,765,221 246,951,093 228,765,221 Ownership Percentage NuScale Corp Class A common stock Beginning of period 36.0 % 30.8 % 33.2 % 30.6 % End of period 37.5 % 32.4 % 37.5 % 32.4 % NuScale LLC Class B Units (NCI) Beginning of period 64.0 % 69.2 % 66.8 % 69.4 % End of period 62.5 % 67.6 % 62.5 % 67.6 %
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per share of Class A common stock. Class B common stock represents a right to cast one vote per share at the NuScale Corp level, and carries no economic rights, including rights to dividends or distributions upon liquidation, and as a result, is not considered a participating security for basic and diluted loss per share. As such, basic and diluted loss per share of Class B common stock has not been presented. As of and for the Three Months Ended June 30, As of and for the Six Months Ended June 30, (in thousands, except share and per share amounts) 2024 2023 2024 2023 Net loss attributable to Class A common stockholders $ (27,617) $ (9,523) $ (44,189) $ (20,485) Weighted-average shares for basic and diluted loss per share 89,553,679 72,125,375 84,569,371 70,913,646 Basic and Diluted loss per share of Class A common stock $ (0.31) $ (0.13) $ (0.52) $ (0.29) Anti-dilutive securities excluded from shares outstanding: Shares of Class B common stock 154,464,735 154,720,015 154,464,735 154,720,015 Stock options 9,884,004 10,413,895 9,884,004 10,413,895 Warrants 18,458,701 18,458,701 18,458,701 18,458,701 Time-based RSUs 5,975,343 3,301,761 5,975,343 3,301,761 Total 188,782,783 186,894,372 188,782,783 186,894,372

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Liabilities Measured on Recurring Basis	The following tables represents the Company’s financial liabilities measured at fair value on a recurring basis: (in thousands) Level 1 Level 2 Level 3 Total Warrant Liabilities: Public Warrants $ 51,500 $ — $ — $ 51,500 Total Warrant Liabilities as of June 30, 2024 $ 51,500 $ — $ — $ 51,500 (in thousands) Level 1 Level 2 Level 3 Total Warrant Liabilities: Public Warrants $ 2,963 $ — $ — $ 2,963 Private Placement Warrants — 2,759 — 2,759 Total Warrant Liabilities as of December 31, 2023 $ 2,963 $ 2,759 $ — $ 5,722

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment consisted of the following: (in thousands) June 30, 2024 December 31, 2023 Furniture and fixtures $ 27 $ 27 Office and computer equipment 7,222 7,274 Software 13,898 14,102 Operations equipment 1,165 1,165 Leasehold improvements 2,189 2,293 24,501 24,861 Less: Accumulated depreciation (21,351) (20,745) Net property, plant and equipment $ 3,150 $ 4,116

Nature of Business (Details)

Nature of Business (Details) $ in Thousands	Jan. 05, 2024 employee	Jun. 30, 2024 USD ($) MW
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of megawatts (mw) | MW		77
Number of positions eliminated | employee	154
Transition percentage	28%
Restructuring charges | $		$ 3,236

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other expenses	$ (13,036)	$ (12,896)	$ (25,139)	$ (28,192)
Research and development expenses	12,132	26,932	25,287	54,502
Restricted cash	5,100		5,100		$ 5,100
Prepaid and other assets noncurrent portion	7,500		7,500		$ 15,000
United State Trade and Development Agency | Government
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collaborative arrangement, cost share	2,397	6,882	5,192	9,297
Nuscale SMR FOAK Nuclear Demonstration Readiness Project Completion
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collaborative arrangement, cost share	0	7,193	336	19,547
CFPP LLC | Government
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collaborative arrangement, government cost share	$ 51	$ 2,165	$ 316	5,104
Revision of Prior Period, Reclassification, Adjustment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other expenses				1,855
Research and development expenses				$ 1,855

Noncontrolling Interests and _3

Noncontrolling Interests and Loss Per Share - Schedule of Non-Controlling Interests (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Noncontrolling Interest [Roll Forward]
Beginning of period (shares)	241,233,638	227,151,875	231,372,198	226,443,839
Issuance of Class A common stock (shares)	4,198,064	0	12,696,994	0
Exercise of options and warrants and vested RSUs (shares)	1,519,391	1,613,346	2,881,901	2,321,382
End of period (shares)	246,951,093	228,765,221	246,951,093	228,765,221
Class A
Noncontrolling Interest [Roll Forward]
Beginning of period (shares)	86,760,243	70,061,055	76,895,166	69,353,019
Exchange of combined interests into Class A common stock (shares)	8,660	2,370,805	12,297	2,370,805
Issuance of Class A common stock (shares)	4,198,064	0	12,696,994	0
Exercise of options and warrants and vested RSUs (shares)	1,519,391	1,613,346	2,881,901	2,321,382
End of period (shares)	92,486,358	74,045,206	92,486,358	74,045,206
Class A | NuScale Corp
Controlling and Non Controlling Interest [Roll Forward]
Beginning of period	36%	30.80%	33.20%	30.60%
End of period	37.50%	32.40%	37.50%	32.40%
Class B
Noncontrolling Interest [Roll Forward]
Beginning of period (shares)	154,473,395	157,090,820	154,477,032	157,090,820
Exchange of combined interests into Class A common stock (shares)	(8,660)	(2,370,805)	(12,297)	(2,370,805)
End of period (shares)	154,464,735	154,720,015	154,464,735	154,720,015
Class B | NuScale LLC
Controlling and Non Controlling Interest [Roll Forward]
Beginning of period	64%	69.20%	66.80%	69.40%
End of period	62.50%	67.60%	62.50%	67.60%

Noncontrolling Interests and _4

Noncontrolling Interests and Loss Per Share - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended	6 Months Ended
	Aug. 08, 2024 USD ($) shares	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 shares
Class B
Noncontrolling Interest [Line Items]
Common stock, votes per share		1	1
Common stock, shares authorized (shares) | shares		179,000,000	179,000,000	179,000,000
Class A
Noncontrolling Interest [Line Items]
Common stock, shares authorized (shares) | shares		332,000,000	332,000,000	332,000,000
Class A | ATM Program
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (shares) | shares		4,198,064	12,696,994
Sale of stock, price per share (in dollars per share) | $ / shares		$ 7.58	$ 5.87
Proceeds from issuance of common stock gross | $		$ 31,821	$ 74,502
Proceeds from the issuance of common stock, net of issuance fees | $		$ 31,025	$ 72,639
Common stock, shares authorized (shares) | shares		5,565,628	5,565,628
Sale of stock, consideration received per transaction | $			$ 65,142
Class A | ATM Program | Subsequent Event
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (shares) | shares	1,420,391
Proceeds from issuance of common stock gross | $	$ 18,858
Proceeds from the issuance of common stock, net of issuance fees | $	$ 18,386

Noncontrolling Interests and _5

Noncontrolling Interests and Loss Per Share - Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Noncontrolling Interest And Loss Per Share [Abstract]
Net loss attributable to Class A common stockholders, basic	$ (27,617)	$ (9,523)	$ (44,189)	$ (20,485)
Net loss attributable to Class A common stockholders, diluted	$ (27,617)	$ (9,523)	$ (44,189)	$ (20,485)
Weighted-average shares for basic loss per share (shares)	89,553,679	72,125,375	84,569,371	70,913,646
Weighted-average shares for diluted loss per share (shares)	89,553,679	72,125,375	84,569,371	70,913,646
Basic loss per share of Class A common stock (usd per share)	$ (0.31)	$ (0.13)	$ (0.52)	$ (0.29)
Diluted loss per share of Class A common stock (usd per share)	$ (0.31)	$ (0.13)	$ (0.52)	$ (0.29)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded (shares)	188,782,783	186,894,372	188,782,783	186,894,372
Shares of Class B common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded (shares)	154,464,735	154,720,015	154,464,735	154,720,015
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded (shares)	9,884,004	10,413,895	9,884,004	10,413,895
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded (shares)	18,458,701	18,458,701	18,458,701	18,458,701
Time-based RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded (shares)	5,975,343	3,301,761	5,975,343	3,301,761

Warrant Liabilities (Details)

Warrant Liabilities (Details)	6 Months Ended
	Jun. 30, 2024 day $ / shares shares
Derivative [Line Items]
Warrants and rights outstanding, term	5 years
Warrant Redemption Scenario One
Derivative [Line Items]
Stock price trigger (usd per share) | $ / shares	$ 18
Redemption price (usd per share) | $ / shares	$ 0.01
Prior written notice period for redemption	30 days
Threshold trading days	20
Threshold consecutive trading day period	30
Redemption period	30
Warrant Redemption Scenario Two
Derivative [Line Items]
Stock price trigger (usd per share) | $ / shares	$ 10
Redemption price (usd per share) | $ / shares	$ 0.10
Prior written notice period for redemption	30 days
Threshold trading days	20
Threshold consecutive trading day period	30
Public Warrants
Derivative [Line Items]
Class of warrant outstanding (shares) | shares	18,458,701

Fair Value Measurement (Details

Fair Value Measurement (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	$ 51,500	$ 5,722
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	51,500	5,722
Fair Value, Recurring | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	51,500	2,963
Fair Value, Recurring | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities		2,759
Level 1 | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	51,500	2,963
Level 1 | Fair Value, Recurring | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	51,500	2,963
Level 1 | Fair Value, Recurring | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities		0
Level 2 | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0	2,759
Level 2 | Fair Value, Recurring | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0	0
Level 2 | Fair Value, Recurring | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities		2,759
Level 3 | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	0	0
Level 3 | Fair Value, Recurring | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities	$ 0	0
Level 3 | Fair Value, Recurring | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liabilities		$ 0

Accounts and Other Receivables

Accounts and Other Receivables (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Receivables [Abstract]
DOE cost share liabilities	$ 431	$ 318

Property, Plant and Equipment -

Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Less: Accumulated depreciation	$ (21,351)	$ (20,745)
Net property, plant and equipment	3,150	4,116
Depreciable Property, Plant And Equipment
Property, Plant and Equipment [Line Items]
Total property, plant and equipment gross	24,501	24,861
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property, plant and equipment gross	27	27
Office and computer equipment
Property, Plant and Equipment [Line Items]
Total property, plant and equipment gross	7,222	7,274
Software
Property, Plant and Equipment [Line Items]
Total property, plant and equipment gross	13,898	14,102
Operations equipment
Property, Plant and Equipment [Line Items]
Total property, plant and equipment gross	1,165	1,165
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property, plant and equipment gross	$ 2,189	$ 2,293

Property, Plant and Equipment_2

Property, Plant and Equipment - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Property, Plant and Equipment [Line Items]
Depreciation	$ 402	$ 556	$ 892	$ 1,172
General and Administrative Expense
Property, Plant and Equipment [Line Items]
Depreciation	80	137	174	277
Other Expense
Property, Plant and Equipment [Line Items]
Depreciation	$ 322	$ 419	$ 718	$ 895

Long-Lead Material Work In Pr_2

Long-Lead Material Work In Process and Liability (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Nov. 07, 2023	Mar. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Purchase of certain long-lead materials	$ 32,445	$ 32,323
Restricted cash	5,100	5,100
Long-lead material work in process	41,227	36,361
CFPP LLC | Long Lead Material Contract
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Purchase of certain long-lead materials	$ 32,445	$ 32,445		$ 55,700
Settlement and release agreement, initial payment, agreed amount			$ 49,769
Letters of credit			$ 5
Estimated cost percentage	100%	100%
Long-lead material work in process	$ 41,227	$ 36,361

Noncurrent Accounts Payable a_2

Noncurrent Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Reclassification [Line Items]
Accounts payable and accrued expenses	$ (19,098)	$ (44,925)
Noncurrent accounts payable and accrued expenses	24,880	$ 0
Reclassification, Other
Reclassification [Line Items]
Accounts payable and accrued expenses	24,880
Noncurrent accounts payable and accrued expenses	$ 24,880

Employee Benefits (Details)

Employee Benefits (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan expense	$ 526	$ 691	$ 1,139	$ 1,442
Defined Contribution Plan, Tranche One
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan, employer matching contribution, percent of employees' gross pay			3%
Defined contribution plan, employer matching contribution, percent of match			100%
Defined Contribution Plan, Tranche Two
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plan, employer matching contribution, percent of employees' gross pay			2%
Defined contribution plan, employer matching contribution, percent of match			50%

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate, percent	0%		0%
Provision (benefit) for income taxes	$ 0	$ 0	$ 0	$ 0

Equity-Based Compensation - Nar

Equity-Based Compensation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement, Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation expense	$ 4,277	$ 4,453	$ 6,496	$ 8,090
Granted (shares)	2,909,375		2,909,375
Shares approved, value	$ 6,401		$ 6,401
Award vesting period (in years)			3 years
Vesting percentage			33.33%
Share-Based Payment Arrangement, Option | General and Administrative Expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation expense	1,981	1,868	$ 3,428	3,361
Share-Based Payment Arrangement, Option | Other Expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation expense	$ 2,296	$ 2,585	$ 3,068	$ 4,729
Time-based RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Granted (shares)	4,598,635		4,598,635
Vested in period, fair value			$ 14,716
Vested (shares)	450,332		918,239
Vesting percentage			33.33%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Related Party Transaction [Line Items]
Revenue	$ 967	$ 5,795	$ 2,346	$ 11,300
Related Party
Related Party Transaction [Line Items]
Accounts payable	1,233		1,233		$ 4,080
Revenue	523	$ 4,756	523	$ 8,770
Accounts and other receivables	$ 523		$ 523		$ 2,642
Related Party | Fluor
Related Party Transaction [Line Items]
Percentage of revenue earned	54%	82%	22%	78%
Services Performed
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction	$ 291	$ 8,479	$ 538	$ 17,205

Commitment and Contingencies (D

Commitment and Contingencies (Details)		1 Months Ended
	Sep. 19, 2022 plaintiff	Dec. 26, 2023 lawsuit
Commitments and Contingencies Disclosure [Abstract]
Number of plaintiffs | plaintiff	13
Number of additional lawsuits | lawsuit		2